อ่านเพิ่มเติม
medical-leaders-thailand.com
Pfizer To Provide U.S. Government With 10 Million Treatment Courses Of Investigational Oral Antiviral Candidate To Help Combat COVID-19
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced an agreement with the U.S. government to supply 10 million treatment courses of its investigational COVID-19 oral antiviral candidate, PAXLOVID™ (PF-07321332; ritonavir), subject to regulatory authorization from the U.S. Food and Dr…